The DOI matches its Crossref record; 549 of the 549 references it cites were found in a registry or an index.
Metabolic reprogramming and epigenetic modifications on the path to cancer
Open accessAbstract
Metabolic rewiring and epigenetic remodeling, which are closely linked and reciprocally regulate each other, are among the well-known cancer hallmarks. Recent evidence suggests that many metabolites serve as substrates or cofactors of chromatin-modifying enzymes as a consequence of the translocation or spatial regionalization of enzymes or metabolites. Various metabolic alterations and epigenetic modifications also reportedly drive immune escape or impede immunosurveillance within certain contexts, playing important roles in tumor progression. In this review, we focus on how metabolic reprogramming of tumor cells and immune cells reshapes epigenetic alterations, in particular the acetylation and methylation of histone proteins and DNA. We also discuss other eminent metabolic modifications such as, succinylation, hydroxybutyrylation, and lactylation, and update the current advances in metabolism- and epigenetic modification-based therapeutic prospects in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–400 of 549
TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS
Deplus, R., Delatte, B., Schwinn, M. K., Defrance, M., Méndez, J., Murphy, N., Dawson, M. A., Volkmar, M., Putmans, P., Calonne, E., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2012.357 · Cited by 486
MTAP deletions in cancer create vulnerability to targeting of the MAT2A/PRMT5/RIOK1 axis
Marjon, K., Cameron, M. J., Quang, P., Clasquin, M. F., Mandley, E., Kunii, K., McVay, M., Choe, S., Kernytsky, A., Gross, S., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.03.043 · Cited by 485 · cited 1×
“…of methionine metabolism and makes tumor cells more sensitive to protein arginine N-methyltransferase 5 (PRMT5) inhibitors, creating a new therapeutic opportunity based on methionine metabolism and epigenomic interactions (Kryukov et al., 2016; Marjon et al., 2016; Mavrakis et al., 2016).”
BackgroundRequirement of Rsk-2 for Epidermal Growth Factor-Activated Phosphorylation of Histone H3
Sassone-Corsi, P., Mizzen, C. A., Cheung, P., Crosio, C., Monaco, L., Jacquot, S., Hanauer, A., & Allis, C. D. (1999) · Science · doi:10.1126/science.285.5429.886 · Cited by 484
Acetate functions as an epigenetic metabolite to promote lipid synthesis under hypoxia
Gao, X., Lin, S.-H., Ren, F., Li, J.-T., Chen, J.-J., Yao, C.-B., Yang, H.-B., Jiang, S.-X., Yan, G.-Q., Wang, D., et al. (2016) · Nature Communications · doi:10.1038/ncomms11960 · Cited by 480
AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations
Yen, K., Travins, J., Wang, F., David, M. D., Artin, E., Straley, K., Padyana, A., Gross, S., DeLaBarre, B., Tobin, E., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-1034 · Cited by 471 · cited 2×
“AG-221, another selective inhibitor of the mutant IDH2 enzyme, suppresses 2HG production and induces the differentiation of both human AML cells and mouse model cells (Yen et al., 2017).”
BackgroundIdentification of High-Copy Disruptors of Telomeric Silencing in Saccharomyces cerevisiae
Singer, M. S., Kahana, A., Wolf, A. J., Meisinger, L. L., Peterson, S. E., Goggin, C., Mahowald, M., & Gottschling, D. E. (1998) · Genetics · doi:10.1093/genetics/150.2.613 · Cited by 467
Vidali, G., Boffa, L. C., Bradbury, E. M., & Allfrey, V. G. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.5.2239 · Cited by 461
O-GlcNAc signalling: implications for cancer cell biology
Slawson, C., & Hart, G. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3114 · Cited by 458
Akt-mTORC1 signaling regulates Acly to integrate metabolic input to control of macrophage activation
Covarrubias, A. J., Aksoylar, H. I., Yu, J., Snyder, N. W., Worth, A. J., Iyer, S. S., Wang, J., Ben-Sahra, I., Byles, V., Polynne-Stapornkul, T., et al. (2016) · eLife · doi:10.7554/elife.11612 · Cited by 456
Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation.
Soria, J., Lee, H., Lee, J. I., Luo, W., Issa, J. J., Kemp, B. L., Liu, D. D., Kurie, J. M., Mao, L., & Khuri, F. R. (2002) · PubMed · Cited by 455
Adams, R. R., Maiato, H., Earnshaw, W. C., & Carmena, M. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.4.865 · Cited by 453
Oncogenic Isocitrate Dehydrogenase Mutations: Mechanisms, Models, and Clinical Opportunities
Cairns, R. A., & Mak, T. W. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0083 · Cited by 452
Calcium orchestrates apoptosis
Mattson, M. P., & Chan, S. L. (2003) · Nature Cell Biology · doi:10.1038/ncb1203-1041 · Cited by 451
Knight, J. S., Subramanian, V., O'Dell, A. A., Yalavarthi, S., Zhao, W., Smith, C. K., Hodgin, J. B., Thompson, P. R., & Kaplan, M. J. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205365 · Cited by 443
Ferrer, C. M., Lynch, T. P., Sodi, V. L., Falcone, J. N., Schwab, L. P., Peacock, D. L., Vocadlo, D. J., Seagroves, T. N., & Reginato, M. J. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.04.026 · Cited by 442
Maddocks, O. D. K., Labuschagne, C. F., Adams, P. D., & Vousden, K. H. (2016) · Molecular Cell · doi:10.1016/j.molcel.2015.12.014 · Cited by 440
Takahashi, H., McCaffery, J. M., Irizarry, R. A., & Boeke, J. D. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.05.040 · Cited by 438 · cited 2×
“…to those showing ACLY-deficient budding yeast reliance on acetate for acetyl-CoA synthesis (De Virgilio et al., 1992; van den Berg et al., 1996; Takahashi et al., 2006), Comerford et al. showed that ACSS2 is the major enzyme required for acetate uptake and utilization and further incorporation…”
BackgroundLauterbach, M. A., Hanke, J. E., Serefidou, M., Mangan, M. S. J., Kolbe, C.-C., Hess, T., Rothe, M., Kaiser, R., Hoss, F., Gehlen, J., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.11.009 · Cited by 434
S-2-hydroxyglutarate regulates CD8(+) T-lymphocyte fate
Tyrakis, P. A., Palazon, A., Macias, D., Lee, K. L., Phan, A. T., Veliça, P., You, J., Chia, G. S., Sim, J., Doedens, A., et al. (2016) · Nature · doi:10.1038/nature20165 · Cited by 433 · cited 1×
“L2HG induction or supplementation enhances the proliferation, long-term persistence and antitumor capacity of adoptively transferred CD8+ Tcells (Tyrakis et al., 2016; Cairns and Mak, 2017).”
BackgroundDe novo NAD+ synthesis enhances mitochondrial function and improves health
Katsyuba, E., Mottis, A., Zietak, M., De Franco, F., van der Velpen, V., Gariani, K., Ryu, D., Cialabrini, L., Matilainen, O., Liscio, P., et al. (2018) · Nature · doi:10.1038/s41586-018-0645-6 · Cited by 430
Metabolic Regulation by Lysine Malonylation, Succinylation, and Glutarylation
Hirschey, M. D., & Zhao, Y. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r114.046664 · Cited by 427
Sirtuins — novel therapeutic targets to treat age-associated diseases
Lavu, S., Boss, O., Elliott, P. J., & Lambert, P. D. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2665 · Cited by 426
Approval Summary: Azacitidine for Treatment of Myelodysplastic Syndrome Subtypes
Kaminskas, E., Farrell, A., Abraham, S., Baird, A., Hsieh, L.-S., Lee, S.-L., Leighton, J. K., Patel, H., Rahman, A., Sridhara, R., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2135 · Cited by 423
Metabolic control of epigenetics in cancer
Kinnaird, A., Zhao, S., Wellen, K. E., & Michelakis, E. D. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.82 · Cited by 420
WSTF regulates the H2A.X DNA damage response via a novel tyrosine kinase activity
Xiao, A., Li, H., Shechter, D., Ahn, S. H., Fabrizio, L. A., Erdjument-Bromage, H., Ishibe-Murakami, S., Wang, B., Tempst, P., Hofmann, K., et al. (2009) · Nature · doi:10.1038/nature07668 · Cited by 416
Jiang, W., Wang, S., Xiao, M., Lin, Y., Zhou, L., Lei, Q., Xiong, Y., Guan, K.-L., & Zhao, S. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.04.028 · Cited by 415
Citrullination regulates pluripotency and histone H1 binding to chromatin
Christophorou, M. A., Castelo-Branco, G., Halley-Stott, R. P., Oliveira, C. S., Loos, R., Radzisheuskaya, A., Mowen, K. A., Bertone, P., Silva, J. C. R., Zernicka-Goetz, M., et al. (2014) · Nature · doi:10.1038/nature12942 · Cited by 412
Histone Phosphorylation: Stimulation by Adenosine 3′,5′-Monophosphate
Langan, T. A. (1968) · Science · doi:10.1126/science.162.3853.579 · Cited by 405
Nutrient Regulation of Signaling, Transcription, and Cell Physiology by O-GlcNAcylation
Hardivillé, S., & Hart, G. W. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.07.014 · Cited by 402
RNA polymerase II is a glycoprotein. Modification of the COOH-terminal domain by O-GlcNAc
Kelly, W. G., Dahmus, M. E., & Hart, G. W. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82216-5 · Cited by 397
Epigenetic regulation of macrophage polarization and function
Ivashkiv, L. B. (2013) · Trends in Immunology · doi:10.1016/j.it.2012.11.001 · Cited by 396
ATP-citrate lyase controls a glucose-to-acetate metabolic switch
Zhao, S., Torres, A., Henry, R. A., Trefely, S., Wallace, M., Lee, J. V., Carrer, A., Sengupta, A., Campbell, S. L., Kuo, Y.-M., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.069 · Cited by 394
Krebs Cycle Reimagined: The Emerging Roles of Succinate and Itaconate as Signal Transducers
Murphy, M. P., & O’Neill, L. A. J. (2018) · Cell · doi:10.1016/j.cell.2018.07.030 · Cited by 392
Itaconic acid is a mammalian metabolite induced during macrophage activation
Strelko, C. L., Lu, W., Dufort, F. J., Seyfried, T. N., Chiles, T. C., Rabinowitz, J. D., & Roberts, M. F. (2011) · Journal of the American Chemical Society · doi:10.1021/ja2070889 · Cited by 391 · cited 4×
“…from cis-aconitate in the TCA cycle of macrophages and is activated by a variety of factors, including LPS and other Toll-like receptor ligands and cytokines, such as type I and type II interferons (Shin et al., 2011; Strelko et al., 2011; Sugimoto et al., 2011; Michelucci et al., 2013).”
BackgroundInfluentialLi, L., Shi, L., Yang, S., Yan, R., Zhang, D., Yang, J., He, L., Li, W., Yi, X., Sun, L., et al. (2016) · Nature Communications · doi:10.1038/ncomms12235 · Cited by 391
Self-citationDomínguez-Andrés, J., Novakovic, B., Li, Y., Scicluna, B. P., Gresnigt, M. S., Arts, R. J. W., Oosting, M., Moorlag, S. J. C. F. M., Groh, L. A., Zwaag, J., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.09.003 · Cited by 390
Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth
Lin, R., Tao, R., Gao, X., Li, T., Zhou, X., Guan, K.-L., Xiong, Y., & Lei, Q.-Y. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.07.002 · Cited by 384
Recruitment of O-GlcNAc Transferase to Promoters by Corepressor mSin3A
Yang, X., Zhang, F., & Kudlow, J. E. (2002) · Cell · doi:10.1016/s0092-8674(02)00810-3 · Cited by 381
High-fructose corn syrup enhances intestinal tumor growth in mice
Goncalves, M. D., Lu, C., Tutnauer, J., Hartman, T. E., Hwang, S.-K., Murphy, C. J., Pauli, C., Morris, R., Taylor, S., Bosch, K., et al. (2019) · Science · doi:10.1126/science.aat8515 · Cited by 374 · cited 1×
“…bodies (Xia et al., 2017; Hopkins et al., 2018), choline (Romano et al., 2017), arginine (PoilletPerez et al., 2018), glutamine (Ishak Gabra et al., 2020), fructose (Goncalves et al., 2019; Zhao et al., 2020), or cysteine (Badgley et al., 2020) mediates the progression of multiple types of cancer.”
Backgroundβ- N -acetylglucosamine (O-GlcNAc) is part of the histone code
Sakabe, K., Wang, Z., & Hart, G. W. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009023107 · Cited by 373
Signaling Kinase AMPK Activates Stress-Promoted Transcription via Histone H2B Phosphorylation
Bungard, D., Fuerth, B. J., Zeng, P.-Y., Faubert, B., Maas, N. L., Viollet, B., Carling, D., Thompson, C. B., Jones, R. G., & Berger, S. L. (2010) · Science · doi:10.1126/science.1191241 · Cited by 372
Mayya, V., Lundgren, D. H., Hwang, S.-I., Rezaul, K., Wu, L., Eng, J. K., Rodionov, V., & Han, D. K. (2009) · Science Signaling · doi:10.1126/scisignal.2000007 · Cited by 372
Lo, W.-S., Duggan, L., Tolga, N. C., Emre, Belotserkovskya, R., Lane, W. S., Shiekhattar, R., & Berger, S. L. (2001) · Science · doi:10.1126/science.1062322 · Cited by 369
Pan, M., Reid, M. A., Lowman, X. H., Kulkarni, R. P., Tran, T. Q., Liu, X., Yang, Y., Hernandez-Davies, J. E., Rosales, K. K., Li, H., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3410 · Cited by 368
Oldham, W. M., Clish, C. B., Yang, Y., & Loscalzo, J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.06.021 · Cited by 364 · cited 2×
“L2HG accumulation is necessary and sufficient for the activation of H3K9me3 and repressive histone methylation (Intlekofer et al., 2015) and inhibits electron transport and glycolysis to alleviate reductive stress (Oldham et al., 2015).”
BackgroundDependence of Mouse Embryonic Stem Cells on Threonine Catabolism
Wang, J., Alexander, P., Wu, L., Hammer, R., Cleaver, O., & McKnight, S. L. (2009) · Science · doi:10.1126/science.1173288 · Cited by 364
Metabolic reprogramming for cancer cells and their microenvironment: Beyond the Warburg Effect
Sun, L., Suo, C., Li, S.-T., Zhang, H., & Gao, P. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.06.005 · Cited by 363
Self-citationAutophagy maintains tumour growth through circulating arginine
Poillet-Perez, L., Xie, X., Zhan, L., Yang, Y., Sharp, D. W., Hu, Z. S., Su, X., Maganti, A., Jiang, C., Lu, W., et al. (2018) · Nature · doi:10.1038/s41586-018-0697-7 · Cited by 360
Harutyunyan, A. S., Krug, B., Chen, H., Papillon-Cavanagh, S., Zeinieh, M., De Jay, N., Deshmukh, S., Chen, C. C. L., Belle, J., Mikael, L. G., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09140-x · Cited by 360
Nucleus-Translocated ACSS2 Promotes Gene Transcription for Lysosomal Biogenesis and Autophagy
Li, X., Yu, W., Qian, X., Xia, Y., Zheng, Y., Lee, J.-H., Li, W., Lyu, J., Rao, G., Zhang, X., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.04.026 · Cited by 356
SIRT5 regulation of ammonia-induced autophagy and mitophagy
Polletta, L., Vernucci, E., Carnevale, I., Arcangeli, T., Rotili, D., Palmerio, S., Steegborn, C., Nowak, T., Schutkowski, M., Pellegrini, L., et al. (2015) · Autophagy · doi:10.1080/15548627.2015.1009778 · Cited by 350
LKB1 loss links serine metabolism to DNA methylation and tumorigenesis
Kottakis, F., Nicolay, B. N., Roumane, A., Karnik, R., Gu, H., Nagle, J. M., Boukhali, M., Hayward, M. C., Li, Y. Y., Chen, T., et al. (2016) · Nature · doi:10.1038/nature20132 · Cited by 348
A Polycomb Repression Signature in Metastatic Prostate Cancer Predicts Cancer Outcome
Yu, J., Yu, J., Rhodes, D. R., Tomlins, S. A., Cao, X., Chen, G., Mehra, R., Wang, X., Ghosh, D., Shah, R. B., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2498 · Cited by 348
Nutrient regulation of signaling and transcription
Hart, G. W. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.aw119.003226 · Cited by 345
Metabolism of [U‐ 13 C]glucose in human brain tumors in vivo
Maher, E. A., Marin‐Valencia, I., Bachoo, R. M., Mashimo, T., Raisanen, J., Hatanpaa, K. J., Jindal, A., Jeffrey, F. M., Choi, C., Madden, C., et al. (2012) · NMR in Biomedicine · doi:10.1002/nbm.2794 · Cited by 341
Wang, F., Wang, K., Xu, W., Zhao, S., Ye, D., Wang, Y., Xu, Y., Zhou, L., Chu, Y., Zhang, C., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.065 · Cited by 340
O-GlcNAc Regulates FoxO Activation in Response to Glucose
Housley, M. P., Rodgers, J. T., Udeshi, N. D., Kelly, T. J., Shabanowitz, J., Hunt, D. F., Puigserver, P., & Hart, G. W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802240200 · Cited by 336
Hitosugi, T., Fan, J., Chung, T.-W., Lythgoe, K., Wang, X., Xie, J., Ge, Q., Gu, T.-L., Polakiewicz, R. D., Roesel, J. L., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.10.015 · Cited by 334
Lv, L., Xu, Y.-P., Zhao, D., Li, F.-L., Wang, W., Sasaki, N., Jiang, Y., Zhou, X., Li, T.-T., Guan, K.-L., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.09.004 · Cited by 334
Latham, T., Mackay, L., Sproul, D., Karim, M., Culley, J., Harrison, D. J., Hayward, L., Langridge-Smith, P., Gilbert, N., & Ramsahoye, B. H. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks066 · Cited by 333
Carrico, C., Meyer, J. G., He, W., Gibson, B. W., & Verdin, E. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.01.016 · Cited by 331 · cited 1×
“These results demonstrate that SIRT5 is a global regulator of lysine succinylation in the cytosol, mitochondria, and nucleus and indicate mechanisms for preventing tumorigenesis by modulating protein succinylation (Park et al., 2013; Rardin et al., 2013; Stram and Payne, 2016; Carrico et al., 2018).”
BackgroundCurcumin is a potent DNA hypomethylation agent
Liu, Z., Xie, Z., Jones, W., Pavlovicz, R. E., Liu, S., Yu, J., Li, P.-K., Lin, J., Fuchs, J. R., Marcucci, G., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.12.041 · Cited by 330
β-hydroxybutyrate: Much more than a metabolite
Newman, J. C., & Verdin, E. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.08.009 · Cited by 326
Vella, P., Scelfo, A., Jammula, S., Chiacchiera, F., Williams, K., Cuomo, A., Roberto, A., Christensen, J., Bonaldi, T., Helin, K., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2012.12.019 · Cited by 326
Hepatic Glucose Sensing via the CREB Coactivator CRTC2
Dentin, R., Hedrick, S., Xie, J., Yates, J., & Montminy, M. (2008) · Science · doi:10.1126/science.1151363 · Cited by 319
Keating, S. T., & El-Osta, A. (2015) · Circulation Research · doi:10.1161/circresaha.116.303936 · Cited by 317
Essential Role of the Glycosyltransferase Sxc/Ogt in Polycomb Repression
Gambetta, M. C., Oktaba, K., & Müller, J. (2009) · Science · doi:10.1126/science.1169727 · Cited by 315
Acetyl-CoA Metabolism Supports Multistep Pancreatic Tumorigenesis
Carrer, A., Trefely, S., Zhao, S., Campbell, S. L., Norgard, R. J., Schultz, K. C., Sidoli, S., Parris, J. L. D., Affronti, H. C., Sivanand, S., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0567 · Cited by 313
S-glycosylation-based cysteine profiling reveals regulation of glycolysis by itaconate
Qin, W., Qin, K., Zhang, Y., Jia, W., Chen, Y., Cheng, B., Peng, L., Chen, N., Liu, Y., Zhou, W., et al. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0323-5 · Cited by 313
Serine restriction alters sphingolipid diversity to constrain tumour growth
Muthusamy, T., Cordes, T., Handzlik, M. K., You, L., Lim, E. W., Gengatharan, J., Pinto, A. F. M., Badur, M. G., Kolar, M. J., Wallace, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2609-x · Cited by 312
Sun, L., Song, L., Wan, Q., Wu, G., Li, X., Wang, Y., Wang, J., Liu, Z., Zhong, X., He, X., et al. (2015) · Cell Research · doi:10.1038/cr.2015.33 · Cited by 310
Self-citationStructure and Biochemical Functions of SIRT6
Pan, P. W., Feldman, J. L., Devries, M. K., Dong, A., Edwards, A. M., & Denu, J. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.218990 · Cited by 310
Witalison, E., Thompson, P., & Hofseth, L. (2015) · Current Drug Targets · doi:10.2174/1389450116666150202160954 · Cited by 310
Oncometabolites suppress DNA repair by disrupting local chromatin signalling
Sulkowski, P. L., Oeck, S., Dow, J., Economos, N. G., Mirfakhraie, L., Liu, Y., Noronha, K., Bao, X., Li, J., Shuch, B. M., et al. (2020) · Nature · doi:10.1038/s41586-020-2363-0 · Cited by 308
Daniels, B. P., Kofman, S. B., Smith, J. R., Norris, G. T., Snyder, A. G., Kolb, J. P., Gao, X., Locasale, J. W., Martinez, J., Gale, M., et al. (2019) · Immunity · doi:10.1016/j.immuni.2018.11.017 · Cited by 307
Dysregulated metabolism contributes to oncogenesis
Hirschey, M. D., DeBerardinis, R. J., Diehl, A. M. E., Drew, J. E., Frezza, C., Green, M. F., Jones, L. W., Ko, Y. H., Le, A., Lea, M. A., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.10.002 · Cited by 305
Mauracher, L. ‐., Posch, F., Martinod, K., Grilz, E., Däullary, T., Hell, L., Brostjan, C., Zielinski, C., Ay, C., Wagner, D. D., et al. (2018) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13951 · Cited by 303
Martínez‐Chantar, M. L., Vázquez‐Chantada, M., Ariz, U., Martínez, N., Varela, M., Luka, Z., Capdevila, A., Rodríguez, J., Aransay, A. M., Matthiesen, R., et al. (2008) · Hepatology · doi:10.1002/hep.22159 · Cited by 302
Disruptor of Telomeric Silencing-1 Is a Chromatin-specific Histone H3 Methyltransferase
Lacoste, N., Utley, R. T., Hunter, J. M., Poirier, G. G., & Côté, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200366200 · Cited by 298
Acetyl-CoA Synthetase 2, a Mitochondrial Matrix Enzyme Involved in the Oxidation of Acetate
Fujino, T., Kondo, J., Ishikawa, M., Morikawa, K., & Yamamoto, T. T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008782200 · Cited by 298
Ruan, H.-B., Han, X., Li, M.-D., Singh, J. P., Qian, K., Azarhoush, S., Zhao, L., Bennett, A. M., Samuel, V. T., Wu, J., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.07.006 · Cited by 296
Nuclear Acetyl-CoA Production by ACLY Promotes Homologous Recombination
Sivanand, S., Rhoades, S., Jiang, Q., Lee, J. V., Benci, J., Zhang, J., Yuan, S., Viney, I., Zhao, S., Carrer, A., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.06.008 · Cited by 295 · cited 1×
“Nuclear localized ACLY is the major source of acetyl-CoA accumulation required for histone acetylation and homologous recombination-mediated DNA repair (Wellen et al., 2009; Linder and Mostoslavsky, 2017; Sivanand et al., 2017) (Fig.”
BackgroundSalvesen, H. B., MacDonald, N., Ryan, A., Jacobs, I. J., Lynch, E. D., Akslen, L. A., & Das, S. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010101)91:1<22::aid-ijc1002>3.0.co;2-s · Cited by 294
Zhou, L., Wang, F., Sun, R., Chen, X., Zhang, M., Xu, Q., Wang, Y., Wang, S., Xiong, Y., Guan, K., et al. (2016) · EMBO reports · doi:10.15252/embr.201541643 · Cited by 294
A proposed role for neutrophil extracellular traps in cancer immunoediting
Berger-Achituv, S., Brinkmann, V., Abed, U. A., Kühn, L. I., Ben-Ezra, J., Elhasid, R., & Zychlinsky, A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00048 · Cited by 288
5-Azacytidine, a new, highly effective cancerostatic
Šorm, F., Pískala, A., Čihák, A., & Veselý, J. (1964) · Experientia · doi:10.1007/bf02135399 · Cited by 286
DNA methyltransferase inhibitors—state of the art
Goffin, J., & Eisenhauer, E. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf314 · Cited by 283
Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitors
Yu, W., Chory, E. J., Wernimont, A. K., Tempel, W., Scopton, A., Federation, A., Marineau, J. J., Qi, J., Barsyte-Lovejoy, D., Yi, J., et al. (2012) · Nature Communications · doi:10.1038/ncomms2304 · Cited by 281
l -2-Hydroxyglutarate: An Epigenetic Modifier and Putative Oncometabolite in Renal Cancer
Shim, E.-H., Livi, C. B., Rakheja, D., Tan, J., Benson, D., Parekh, V., Kho, E.-Y., Ghosh, A. P., Kirkman, R., Velu, S., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0696 · Cited by 280
Global Histone Modifications Predict Prognosis of Resected Non–Small-Cell Lung Cancer
Barlési, F., Giaccone, G., Gallegos-Ruiz, M. I., Loundou, A., Span, S. W., Lefesvre, P., Kruyt, F. A. E., & Rodriguez, J. A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.2599 · Cited by 280
Irg1 expression in myeloid cells prevents immunopathology during M. tuberculosis infection
Nair, S., Huynh, J. P., Lampropoulou, V., Loginicheva, E., Esaulova, E., Gounder, A. P., Boon, A. C. M., Schwarzkopf, E. A., Bradstreet, T. R., Edelson, B. T., et al. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20180118 · Cited by 280
SIRT 5 inhibits peroxisomal ACOX 1 to prevent oxidative damage and is downregulated in liver cancer
Chen, X., Tian, M., Sun, R., Zhang, M., Zhou, L., Jin, L., Chen, L., Zhou, W., Duan, K., Chen, Y., et al. (2018) · EMBO reports · doi:10.15252/embr.201745124 · Cited by 278
SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma
Bayley, J.-P., Kunst, H. P., Cascon, A., Sampietro, M. L., Gaal, J., Korpershoek, E., Hinojar-Gutierrez, A., Timmers, H. J., Hoefsloot, L. H., Hermsen, M. A., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70007-3 · Cited by 276
Merza, M., Hartman, H., Rahman, M., Hwaiz, R., Zhang, E., Renström, E., Luo, L., Mörgelin, M., Regner, S., & Thorlacius, H. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.08.026 · Cited by 273
Zippo, A., De Robertis, A., Serafini, R., & Oliviero, S. (2007) · Nature Cell Biology · doi:10.1038/ncb1618 · Cited by 273
Histone Acetylation Regulates Intracellular pH
McBrian, M. A., Behbahan, I. S., Ferrari, R., Su, T., Huang, T.-W., Li, K., Hong, C. S., Christofk, H. R., Vogelauer, M., Seligson, D. B., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2012.10.025 · Cited by 272
Sirtuins in Epigenetic Regulation
Jing, H., & Lin, H. (2015) · Chemical Reviews · doi:10.1021/cr500457h · Cited by 270
Homeodomain-Mediated β-Catenin-Dependent Switching Events Dictate Cell-Lineage Determination
Olson, L. E., Tollkuhn, J., Scafoglio, C., Krones, A., Zhang, J., Ohgi, K. A., Wu, W., Taketo, M. M., Kemler, R., Grosschedl, R., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.046 · Cited by 270
Itaconic acid mediates crosstalk between macrophage metabolism and peritoneal tumors
Weiss, J. M., Davies, L. C., Karwan, M., Ileva, L., Ozaki, M. K., Cheng, R. Y. S., Ridnour, L. A., Annunziata, C. M., Wink, D. A., & McVicar, D. W. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99169 · Cited by 267 · cited 2×
“, 2014); IRG1-mediated itaconate production potentiates peritoneal tumor growth, and IRG1 in peritoneal tissue-resident macrophages (pResMφ) represents a potential therapeutic target for peritoneal tumors (Weiss et al., 2018).”
BackgroundO-GlcNAcylation in Cancer Biology: Linking Metabolism and Signaling
Ferrer, C. M., Sodi, V. L., & Reginato, M. J. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.05.028 · Cited by 267
Luong, A., Hannah, V. C., Brown, M. S., & Goldstein, J. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004160200 · Cited by 266
Bulusu, V., Tumanov, S., Michalopoulou, E., van den Broek, N. J., MacKay, G., Nixon, C., Dhayade, S., Schug, Z. T., Vande Voorde, J., Blyth, K., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.055 · Cited by 266
Moscarello, M. A., Mastronardi, F. G., & Wood, D. D. (2007) · Neurochemical Research · doi:10.1007/s11064-006-9144-5 · Cited by 264
Goudarzi, A., Zhang, D., Huang, H., Barral, S., Kwon, O. K., Qi, S., Tang, Z., Buchou, T., Vitte, A.-L., He, T., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.03.014 · Cited by 263
Interplay between epigenetics and metabolism in oncogenesis: mechanisms and therapeutic approaches
Wong, C. C., Qian, Y., & Yu, J. (2017) · Oncogene · doi:10.1038/onc.2016.485 · Cited by 262
O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy
Mi, W., Gu, Y., Han, C., Liu, H., Fan, Q., Zhang, X., Cong, Q., & Yu, W. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.01.009 · Cited by 259
Eisenberg, T., Schroeder, S., Andryushkova, A., Pendl, T., Küttner, V., Bhukel, A., Mariño, G., Pietrocola, F., Harger, A., Zimmermann, A., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.02.010 · Cited by 256
Increased PADI4 expression in blood and tissues of patients with malignant tumors
Chang, X., Han, J., Pang, L., Zhao, Y., Yang, Y., & Shen, Z. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-40 · Cited by 255
ATP-citrate lyase: A mini-review
Chypre, M., Zaidi, N., & Smans, K. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.04.144 · Cited by 253
Inhibition of histone deacetylases in cancer therapy: lessons from leukaemia
Ceccacci, E., & Minucci, S. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.36 · Cited by 253
Priming of neutrophils toward NETosis promotes tumor growth
Demers, M., Wong, S. L., Martinod, K., Gallant, M., Cabral, J. E., Wang, Y., & Wagner, D. D. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1134073 · Cited by 252
Xu, D., Shao, F., Bian, X., Meng, Y., Liang, T., & Lu, Z. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2020.12.015 · Cited by 251
Papathanassiu, A. E., Ko, J.-H., Imprialou, M., Bagnati, M., Srivastava, P. K., Vu, H. A., Cucchi, D., McAdoo, S. P., Ananieva, E. A., Mauro, C., et al. (2017) · Nature Communications · doi:10.1038/ncomms16040 · Cited by 250
Acetylation on histone H3 lysine 9 mediates a switch from transcription initiation to elongation
Gates, L. A., Shi, J., Rohira, A. D., Feng, Q., Zhu, B., Bedford, M. T., Sagum, C. A., Jung, S. Y., Qin, J., Tsai, M.-J., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.802074 · Cited by 249
1H NMR-based Metabolomic Profiling in Mice Infected with Mycobacterium tuberculosis
Shin, J.-H., Yang, J.-Y., Jeon, B.-Y., Yoon, Y. J., Cho, S.-N., Kang, Y.-H., Ryu, D. H., & Hwang, G.-S. (2011) · Journal of Proteome Research · doi:10.1021/pr101054m · Cited by 247 · cited 5×
“…from cis-aconitate in the TCA cycle of macrophages and is activated by a variety of factors, including LPS and other Toll-like receptor ligands and cytokines, such as type I and type II interferons (Shin et al., 2011; Strelko et al., 2011; Sugimoto et al., 2011; Michelucci et al., 2013).”
BackgroundInfluentialThe butyrate story: old wine in new bottles?
Scheppach, W., & Weiler, F. (2004) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200409000-00009 · Cited by 246
Caloric restriction mimetics: towards a molecular definition
Madeo, F., Pietrocola, F., Eisenberg, T., & Kroemer, G. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4391 · Cited by 245
van den Berg, M. A., de Jong-Gubbels, P., Kortland, C. J., van Dijken, J. P., Pronk, J. T., & Steensma, H. Y. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.28953 · Cited by 244
Li, F., He, X., Ye, D., Lin, Y., Yu, H., Yao, C., Huang, L., Zhang, J., Wang, F., Xu, S., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.10.017 · Cited by 244
ATP citrate lyase: A central metabolic enzyme in cancer
Icard, P., Wu, Z., Fournel, L., Coquerel, A., Lincet, H., & Alifano, M. (2020) · Cancer Letters · doi:10.1016/j.canlet.2019.12.010 · Cited by 244
Effect of folic acid supplementation on genomic DNA methylation in patients with colorectal adenoma
Pufulete, M., Al-Ghnaniem, R., Khushal, A., Appleby, P., Harris, N., Gout, S., Emery, P. W., & Sanders, T. A. B. (2005) · Gut · doi:10.1136/gut.2004.054718 · Cited by 243
Metabolism, Activity, and Targeting of D- and L-2-Hydroxyglutarates
Ye, D., Guan, K.-L., & Xiong, Y. (2018) · Trends in Cancer · doi:10.1016/j.trecan.2017.12.005 · Cited by 242 · cited 2×
“FAD-dependent D-2-hydroxyglutarate dehydrogenase (D2HGDH) regulates the generation of D2HG in E. coli, yeast, and human cancer cells (Zhao and Winkler, 1996; Fan et al., 2015; Lin et al., 2015; Becker-Kettern et al., 2016; Ye et al., 2018).”
BackgroundPhase 1 trial of dichloroacetate (DCA) in adults with recurrent malignant brain tumors
Dunbar, E. M., Coats, B. S., Shroads, A. L., Langaee, T., Lew, A., Forder, J. R., Shuster, J. J., Wagner, D. A., & Stacpoole, P. W. (2014) · Investigational New Drugs · doi:10.1007/s10637-013-0047-4 · Cited by 241
Specific Contribution of Methionine and Choline in Nutritional Nonalcoholic Steatohepatitis
Caballero, F., Fernández, A., Matías, N., Martínez, L., Fucho, R., Elena, M., Caballeria, J., Morales, A., Fernández-Checa, J. C., & García-Ruiz, C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.099333 · Cited by 238
Histone demethylases in chromatin biology and beyond
Dimitrova, E., Turberfield, A. H., & Klose, R. J. (2015) · EMBO reports · doi:10.15252/embr.201541113 · Cited by 238
Rheumatoid arthritis and citrullination
Darrah, E., & Andrade, F. (2018) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000452 · Cited by 236
Promoter Methylation and Silencing of PTEN in Gastric Carcinoma
Kang, Y.-H., Lee, H. S., & Kim, W. H. (2002) · Laboratory Investigation · doi:10.1038/labinvest.3780422 · Cited by 231
O-GlcNAcylation regulates EZH2 protein stability and function
Chu, C.-S., Lo, P.-W., Yeh, Y.-H., Hsu, P.-H., Peng, S.-H., Teng, Y.-C., Kang, M.-L., Wong, C.-H., & Juan, L.-J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323226111 · Cited by 231
Citrullinated histone H3 as a novel prognostic blood marker in patients with advanced cancer
Thålin, C., Lundström, S., Seignez, C., Daleskog, M., Lundström, A., Henriksson, P., Helleday, T., Phillipson, M., Wallén, H., & Demers, M. (2018) · PLOS ONE · doi:10.1371/journal.pone.0191231 · Cited by 225
Metabolic, Epigenetic, and Transgenerational Effects of Gut Bacterial Choline Consumption
Romano, K. A., Martinez-del Campo, A., Kasahara, K., Chittim, C. L., Vivas, E. I., Amador-Noguez, D., Balskus, E. P., & Rey, F. E. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.07.021 · Cited by 224
Promoter methylation of the PTEN gene is a common molecular change in breast cancer
García, J. M., Silva, J., Peña, C., Garcia, V., Rodríguez, R., Cruz, M. A., Cantos, B., Provencio, M., España, P., & Bonilla, F. (2004) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20062 · Cited by 224
Regulation of p53 Target Gene Expression by Peptidylarginine Deiminase 4
Li, P., Yao, H., Zhang, Z., Li, M., Luo, Y., Thompson, P. R., Gilmour, D. S., & Wang, Y. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01747-07 · Cited by 220
Chromatin plasticity: A versatile landscape that underlies cell fate and identity
Yadav, T., Quivy, J.-P., & Almouzni, G. (2018) · Science · doi:10.1126/science.aat8950 · Cited by 220
Division of labor in Polycomb group repression
Levine, S. S., King, I. F. G., & Kingston, R. E. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.07.007 · Cited by 219
Delivery of 5-Aza-2′-Deoxycytidine to Cells Using Oligodeoxynucleotides
Yoo, C. B., Jeong, S., Egger, G., Liang, G., Phiasivongsa, P., Tang, C., Redkar, S., & Jones, P. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0251 · Cited by 219
Faiola, F., Liu, X., Lo, S., Pan, S., Zhang, K., Lymar, E., Farina, A., & Martinez, E. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.23.10220-10234.2005 · Cited by 218
Lactate Elicits ER-Mitochondrial Mg2+ Dynamics to Integrate Cellular Metabolism
Daw, C. C., Ramachandran, K., Enslow, B. T., Maity, S., Bursic, B., Novello, M. J., Rubannelsonkumar, C. S., Mashal, A. H., Ravichandran, J., Bakewell, T. M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.049 · Cited by 218
Flavonoids from carnation (Dianthus caryophyllus) and their antifungal activity
Galeotti, F., Barile, E., Curir, P., Dolci, M., & Lanzotti, V. (2008) · Phytochemistry Letters · doi:10.1016/j.phytol.2007.10.001 · Cited by 216
Manuyakorn, A., Paulus, R., Farrell, J., Dawson, N. A., Tze, S., Cheung-Lau, G., Hines, O. J., Reber, H., Seligson, D. B., Horvath, S., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.5639 · Cited by 216
Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer
Vanharanta, S., Shu, W., Brenet, F., Hakimi, A. A., Heguy, A., Viale, A., Reuter, V. E., Hsieh, J. J.-D., Scandura, J. M., & Massagué, J. (2013) · Nature Medicine · doi:10.1038/nm.3029 · Cited by 215 · cited 4×
“In addition, many oncogenes and tumor suppressors such as hypoxiainducible factors (HIFs) (Watson et al., 2010; Prickaerts et al., 2016; Nanduri et al., 2017), von Hippel-Lindau tumor suppressor (VHL) (Herman et al., 1994; Schmitt et al., 2009; Vanharanta et al., 2013), Myc (Dang, 2012; Stine et al., 2015; Poole and v…”
BackgroundInfluentialGlcNAcylation Plays an Essential Role in Breast Cancer Metastasis
Gu, Y., Mi, W., Ge, Y., Liu, H., Fan, Q., Han, C., Yang, J., Han, F., Lu, X., & Yu, W. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1887 · Cited by 215
O-GlcNAc Signaling Entrains the Circadian Clock by Inhibiting BMAL1/CLOCK Ubiquitination
Li, M.-D., Ruan, H.-B., Hughes, M. E., Lee, J.-S., Singh, J. P., Jones, S. P., Nitabach, M. N., & Yang, X. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2012.12.015 · Cited by 214
Sulkowski, P. L., Sundaram, R. K., Oeck, S., Corso, C. D., Liu, Y., Noorbakhsh, S., Niger, M., Boeke, M., Ueno, D., Kalathil, A. N., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0170-4 · Cited by 213
Karahoca, M., & Momparler, R. L. (2013) · Clinical Epigenetics · doi:10.1186/1868-7083-5-3 · Cited by 213
Regulation of UCP1 and Mitochondrial Metabolism in Brown Adipose Tissue by Reversible Succinylation
Wang, G., Meyer, J. G., Cai, W., Softic, S., Li, M. E., Verdin, E., Newgard, C., Schilling, B., & Kahn, C. R. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.03.021 · Cited by 212
Requirement for O‐linked N‐acetylglucosaminyltransferase in lymphocytes activation
Golks, A., Tran, T. T., Goetschy, J. F., & Guerini, D. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601845 · Cited by 211
Ma, R., Ji, T., Zhang, H., Dong, W., Chen, X., Xu, P., Chen, D., Liang, X., Yin, X., Liu, Y., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-017-0002-2 · Cited by 211
Self-citationChuang, J. C., Yoo, C. B., Kwan, J. M., Li, T. W. H., Liang, G., Yang, A. S., & Jones, P. A. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0172 · Cited by 210
Asaga, H., Yamada, M., & Senshu, T. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8148 · Cited by 208
Beyond histone acetylation—writing and erasing histone acylations
Zhao, S., Zhang, X., & Li, H. (2018) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2018.10.001 · Cited by 206
Histone levels are regulated by phosphorylation and ubiquitylation-dependent proteolysis
Singh, R. K., Kabbaj, M.-H. M., Paik, J., & Gunjan, A. (2009) · Nature Cell Biology · doi:10.1038/ncb1903 · Cited by 205
Metabolic Regulation of Protein N-Alpha-Acetylation by Bcl-xL Promotes Cell Survival
Yi, C. H., Pan, H., Seebacher, J., Jang, I.-H., Hyberts, S. G., Heffron, G. J., Vander Heiden, M. G., Yang, R., Li, F., Locasale, J. W., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.050 · Cited by 205
Ketogenesis-generated β-hydroxybutyrate is an epigenetic regulator of CD8+ T-cell memory development
Zhang, H., Tang, K., Ma, J., Zhou, L., Liu, J., Zeng, L., Zhu, L., Xu, P., Chen, J., Wei, K., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-019-0440-0 · Cited by 204
Self-citationChung, C., Sweha, S. R., Pratt, D., Tamrazi, B., Panwalkar, P., Banda, A., Bayliss, J., Hawes, D., Yang, F., Lee, H.-J., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.07.008 · Cited by 203
SETD2 Restricts Prostate Cancer Metastasis by Integrating EZH2 and AMPK Signaling Pathways
Yuan, H., Han, Y., Wang, X., Li, N., Liu, Q., Yin, Y., Wang, H., Pan, L., Li, L., Song, K., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.05.022 · Cited by 202
Sadakierska-Chudy, A., & Filip, M. (2015) · Neurotoxicity Research · doi:10.1007/s12640-014-9508-6 · Cited by 201
Human Phosphoglycerate Dehydrogenase Produces the Oncometabolite d-2-Hydroxyglutarate
Fan, J., Teng, X., Liu, L., Mattaini, K. R., Looper, R. E., Vander Heiden, M. G., & Rabinowitz, J. D. (2015) · ACS Chemical Biology · doi:10.1021/cb500683c · Cited by 198
Structure of ATP citrate lyase and the origin of citrate synthase in the Krebs cycle
Verschueren, K. H. G., Blanchet, C., Felix, J., Dansercoer, A., De Vos, D., Bloch, Y., Van Beeumen, J., Svergun, D., Gutsche, I., Savvides, S. N., et al. (2019) · Nature · doi:10.1038/s41586-019-1095-5 · Cited by 198
Onakpoya, I., Hung, S. K., Perry, R. E., Wider, B., & Ernst, E. (2010) · Journal of Obesity · doi:10.1155/2011/509038 · Cited by 195
Overview of the Molecular and Biochemical Basis of Branched-Chain Amino Acid Catabolism
Harris, R. A., Joshi, M., Jeoung, N. H., & Obayashi, M. (2005) · The Journal of Nutrition · doi:10.1093/jn/135.6.1527s · Cited by 194
Chen, J., Guccini, I., Di Mitri, D., Brina, D., Revandkar, A., Sarti, M., Pasquini, E., Alajati, A., Pinton, S., Losa, M., et al. (2018) · Nature Genetics · doi:10.1038/s41588-017-0026-3 · Cited by 194
Takawa, M., Masuda, K., Kunizaki, M., Daigo, Y., Takagi, K., Iwai, Y., Cho, H., Toyokawa, G., Yamane, Y., Maejima, K., et al. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01958.x · Cited by 192
Janke, R., Dodson, A. E., & Rine, J. (2015) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100814-125544 · Cited by 191
Multiple modes of PRC2 inhibition elicit global chromatin alterations in H3K27M pediatric glioma
Stafford, J. M., Lee, C.-H., Voigt, P., Descostes, N., Saldaña-Meyer, R., Yu, J.-R., Leroy, G., Oksuz, O., Chapman, J. R., Suarez, F., et al. (2018) · Science Advances · doi:10.1126/sciadv.aau5935 · Cited by 191
Yuzhalin, A. E., Gordon-Weeks, A. N., Tognoli, M. L., Jones, K., Markelc, B., Konietzny, R., Fischer, R., Muth, A., O’Neill, E., Thompson, P. R., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07306-7 · Cited by 188
Pritzker, L. B., Joshi, S., Gowan, J. J., Harauz, G., & Moscarello, M. A. (2000) · Biochemistry · doi:10.1021/bi9925569 · Cited by 187
Shu, L., Khor, T. O., Lee, J.-H., Boyanapalli, S. S. S., Huang, Y., Wu, T.-Y., Saw, C. L.-L., Cheung, K.-L., & Kong, A.-N. T. (2011) · The AAPS Journal · doi:10.1208/s12248-011-9300-y · Cited by 187
Targeting histone lysine methylation in cancer
McGrath, J., & Trojer, P. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.01.002 · Cited by 186
Carnitine Palmitoyltransferase 1A Has a Lysine Succinyltransferase Activity
Kurmi, K., Hitosugi, S., Wiese, E. K., Boakye-Agyeman, F., Gonsalves, W. I., Lou, Z., Karnitz, L. M., Goetz, M. P., & Hitosugi, T. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.01.030 · Cited by 186
Methionine adenosyltransferase II serves as a transcriptional corepressor of Maf oncoprotein
Katoh, Y., Ikura, T., Hoshikawa, Y., Tashiro, S., Ito, T., Ohta, M., Kera, Y., Noda, T., & Igarashi, K. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.02.018 · Cited by 185
Regulation of Protein Degradation by O-GlcNAcylation: Crosstalk with Ubiquitination
Ruan, H.-B., Nie, Y., & Yang, X. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r113.029751 · Cited by 185
MYC—Master Regulator of the Cancer Epigenome and Transcriptome
Poole, C. J., & Van Riggelen, J. (2017) · Genes · doi:10.3390/genes8050142 · Cited by 183
Control of free arachidonic acid levels by phospholipases A2 and lysophospholipid acyltransferases
Pérez-Chacón, G., Astudillo, A. M., Balgoma, D., Balboa, M. A., & Balsinde, J. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.08.007 · Cited by 182
Bandukwala, H. S., Gagnon, J., Togher, S., Greenbaum, J. A., Lamperti, E. D., Parr, N. J., Molesworth, A. M. H., Smithers, N., Lee, K., Witherington, J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1212264109 · Cited by 181
Psat1-Dependent Fluctuations in α-Ketoglutarate Affect the Timing of ESC Differentiation
Hwang, I.-Y., Kwak, S., Lee, S., Kim, H., Lee, S. E., Kim, J.-H., Kim, Y. A., Jeon, Y. K., Chung, D. H., Jin, X., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.06.014 · Cited by 180
Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome
Esteller, M., Avizienyte, E., Corn, P. G., Lothe, R. A., Baylin, S. B., Aaltonen, L. A., & Herman, J. G. (2000) · Oncogene · doi:10.1038/sj.onc.1203227 · Cited by 179
Bharathi, S. S., Zhang, Y., Mohsen, A.-W., Uppala, R., Balasubramani, M., Schreiber, E., Uechi, G., Beck, M. E., Rardin, M. J., Vockley, J., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.510354 · Cited by 178
Smestad, J. A., Erber, L. N., Chen, Y., & Maher, L. J. (2018) · iScience · doi:10.1016/j.isci.2018.03.012 · Cited by 178
Ballantyne, C. M., Davidson, M. H., MacDougall, D. E., Bays, H. E., DiCarlo, L. A., Rosenberg, N. L., Margulies, J., & Newton, R. S. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.050 · Cited by 175 · cited 1×
“BMS-303141 (preclinical) (Li et al., 2007), ETC-1002 (phase II clinical trial) (Ballantyne et al., 2013; Filippov et al., 2014; Gutierrez et al., 2014), and hydroxycitrate (phase IV clinical trial) (Onakpoya et al., 2011; Madeo et al., 2014) are other ACLY inhibitors in clinical trials.”
BackgroundDiverse involvement of EZH2 in cancer epigenetics.
Völkel, P., Dupret, B., Bourhis, X. L., & Angrand, P. (2015) · PubMed · Cited by 174
Induction of sarcomas by mutant IDH2
Lü, C., Venneti, S., Akalin, A., Fang, F., Ward, P. S., Dematteo, R. G., Intlekofer, A. M., Chen, C., Ye, J., Hameed, M., et al. (2013) · Genes & Development · doi:10.1101/gad.226753.113 · Cited by 173
mTORC2-AKT signaling to ATP-citrate lyase drives brown adipogenesis and de novo lipogenesis
Calejman, C. M., Trefely, S., Entwisle, S. W., Luciano, A. K., Jung, S., Hsiao, W., Torres, A., Hung, C. M., Li, H., Snyder, N. W., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14430-w · Cited by 173
Structure of p300 in complex with acyl-CoA variants
Kaczmarska, Z., Ortega, E., Goudarzi, A., Huang, H., Kim, S., Márquez, J. A., Zhao, Y., Khochbin, S., & Panne, D. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2217 · Cited by 172
Histone Modifiers in Cancer: Friends or Foes?
Cohen, I., Poreba, E., Kamieniarz, K., & Schneider, R. (2011) · Genes & Cancer · doi:10.1177/1947601911417176 · Cited by 171
Morrish, F. M., Noonan, J., Olsen, C. P., Gafken, P. R., Fitzgibbon, M., Kelleher, J. K., VanGilst, M., & Hockenbery, D. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.141606 · Cited by 171
Ketogenic diets: from cancer to mitochondrial diseases and beyond
Branco, A. F., Ferreira, A., Simões, R. F., Novais, S. M., Zehowski, C., Cope, E., Silva, A. M., Pereira, D. J., Sardão, V. A., & Cunha‐Oliveira, T. (2016) · European Journal of Clinical Investigation · doi:10.1111/eci.12591 · Cited by 171
Gutierrez, M. J., Rosenberg, N. L., MacDougall, D. E., Hanselman, J. C., Margulies, J. R., Strange, P., Milad, M. A., McBride, S. J., & Newton, R. S. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.113.302677 · Cited by 170
Chuang, J. C., Warner, S. L., Vollmer, D. L., Vankayalapati, H., Redkar, S., Bearss, D. J., Qiu, X., Yoo, C. B., & Jones, P. A. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-1048 · Cited by 170
Zhang, W., Zhang, S., Hu, X., & Tam, K. Y. (2015) · International Journal of Biological Sciences · doi:10.7150/ijbs.13325 · Cited by 170
Prevention of Dietary-Fat-Fueled Ketogenesis Attenuates BRAF V600E Tumor Growth
Xia, S., Lin, R., Jin, L., Zhao, L., Kang, H.-B., Pan, Y., Liu, S., Qian, G., Qian, Z., Konstantakou, E., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.12.010 · Cited by 170
Nutrient Utilization by Cells Isolated from Rat Jejunum, Cecum and Colon
Fleming, S. E., Fitch, M. D., DeVries, S., Liu, M. L., & Kight, C. (1991) · The Journal of Nutrition · doi:10.1093/jn/121.6.869 · Cited by 168
Regulation of histone modification and chromatin structure by the p53–PADI4 pathway
Tanikawa, C., Espinosa‐Cantellano, M., Suzuki, A., Masuda, K., Yamamoto, K., Tsuchiya, E., Ueda, K., Daigo, Y., Nakamura, Y., & Matsuda, K. (2012) · Nature Communications · doi:10.1038/ncomms1676 · Cited by 166
Cloning and analysis of gene regulation of a novel LPS-inducible cDNA
Lee, C. L., Jenkins, N., Gilbert, D., Copeland, N., & O'Brien, W. (1995) · Immunogenetics · doi:10.1007/bf00172150 · Cited by 165 · cited 1×
“These stimuli increase the expression of aconitate decarboxylase 1 (ACOD1; also known as CAD), previously known as immune-responsive gene 1 (IRG1), which is critical for itaconate production (Lee et al., 1995; Michelucci et al., 2013).”
BackgroundO-GlcNAc and the Epigenetic Regulation of Gene Expression
Lewis, B. A., & Hanover, J. A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.r114.595439 · Cited by 165
PTEN Promoter Methylation in Sporadic Thyroid Carcinomas
Álvarez-Núñez, F., Bussaglia, E., Mauricio, D., Ybarra, J., Vilar, M., Lerma, E., de Leiva, A., & Matías‐Guiu, X. (2006) · Thyroid · doi:10.1089/thy.2006.16.17 · Cited by 164
Desuccinylation of pyruvate kinase M2 by SIRT5 contributes to antioxidant response and tumor growth
Xiangyun, Y., Xiaomin, N., linping, G., Yunhua, X., Ziming, L., Yongfeng, Y., Zhiwei, C., & Shun, L. (2017) · Oncotarget · doi:10.18632/oncotarget.14346 · Cited by 164
p53 β-hydroxybutyrylation attenuates p53 activity
Liu, K., Li, F., Sun, Q., Lin, N., Han, H., You, K., Tian, F., Mao, Z., Li, T., Tong, T., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1463-y · Cited by 164
Understanding the central role of citrate in the metabolism of cancer cells
Icard, P., Poulain, L., & Lincet, H. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.10.007 · Cited by 163
Bianco‐Miotto, T., Chiam, K., Buchanan, G., Jindal, S., Day, T. K., Thomas, M., Pickering, M. A., O'Loughlin, M. A., Ryan, N. K., Raymond, W. A., et al. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0555 · Cited by 163
Epigenetics: The epicenter of the hypoxic response
Watson, J. A., Watson, C. J., McCann, A., & Baugh, J. (2010) · Epigenetics · doi:10.4161/epi.5.4.11684 · Cited by 162
Cited by
Cold and hot tumors: from molecular mechanisms to targeted therapy
Wu, B., Zhang, B., Li, B., Wu, H., & Jiang, M. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01979-x · Cited by 682
Drug repurposing for cancer therapy
Xia, Y., Sun, M., Huang, H., & Jin, W.-L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01808-1 · Cited by 443
Li, F., Si, W., Xia, L., Yin, D., Wei, T., Tao, M., Cui, X., Yang, J., Hong, T., & Wei, R. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02008-9 · Cited by 390
Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets
Yang, J., Xu, J., Wang, W., Zhang, B., Yu, X., & Shi, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01480-x · Cited by 388
Ju, J., Zhang, H., Lin, M., Yan, Z., An, L., Cao, Z., Geng, D., Yue, J., Tang, Y., Tian, L., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci174587 · Cited by 338
Self-citation
Metadata
- Authors
- Sun, L., Zhang, H., & Gao, P.
- Venue
- Protein & Cell
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-05-29
- Volume
- 13
- Issue
- 12
- Pages
- 877-919
- ISSN
- 1674-800X (ISSN-L)
- 1674-8018
- OpenAlex
- W3165482261
- Cited by
- 770
- References
- 549
- FWCI
- 26.70
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.